Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Correction of Bacterial Overgrowth Syndrome in the Small Intestine on Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction

NCT06652087 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.

NCT NCT06652087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06652087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Correction of Bacterial Overgrowth Syndrome in the Small Intestine on Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction
Lead sponsor
I.M. Sechenov First Moscow State Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
September 2, 2024
Completion date
September 30, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial overgrowth syndrome small bowel, heart failure with preserved ejection fraction